In July 2025, Zinzino reported a 55% revenue increase, amounting to SEK 262.1 million, compared to SEK 169.1 million in July 2024. This growth reflects the company’s expanding presence across various regions, driving its success in the global direct sales market.
On the other hand, Faun Pharma saw a decline in external sales, which dropped to SEK 2.2 million, down from SEK 10.3 million in the same period last year.
The Zinzino Group saw an overall increase of 64%, with total revenue reaching SEK 259.9 million, up from SEK 158.8 million in 2024. This marks a significant step forward for the company’s continued growth trajectory.
July 2025: SEK 26.1 million (12% increase)
YTD 2025: SEK 181.3 million (10% increase)
July 2025: SEK 76.1 million (73% increase)
YTD 2025: SEK 491.1 million (64% increase)
July 2025: SEK 31.3 million (8% increase)
YTD 2025: SEK 217.8 million (1% decrease)
July 2025: SEK 47.3 million (42% increase)
YTD 2025: SEK 309.3 million (60% increase)
July 2025: SEK 10.0 million (25% increase)
YTD 2025: SEK 66.8 million (20% increase)
July 2025: SEK 47.2 million (183% increase)
YTD 2025: SEK 299.5 million (205% increase)
July 2025: SEK 20.0 million (590% increase)
YTD 2025: SEK 169.0 million (499% increase)
July 2025: SEK 1.9 million (36% increase)
YTD 2025: SEK 12.1 million (46% increase)
The accumulated revenue for the first seven months of 2025 saw a 57% increase, reaching SEK 1,780.1 million, compared to SEK 1,130.7 million in the same period of 2024.
Zinzino operates in over 100 markets worldwide, including key regions such as:
The Nordics: Denmark, Faroe Islands, Finland, Iceland, Norway, Sweden
Central Europe: Austria, Germany, Switzerland
East Europe: Czech Republic, Slovakia, Hungary, Poland, Romania
South & West Europe: Cyprus, France, Greece, Italy, Luxembourg, Malta, Netherlands, Slovenia, Spain, United Kingdom, Belgium, Ireland, Serbia, Turkey, Canary Islands
The Baltics: Estonia, Latvia, Lithuania
North America: Canada, USA, Mexico
Asia-Pacific: Australia, New Zealand, Hong Kong, India, Malaysia, Singapore, Taiwan, Thailand, China, Philippines
Africa: South Africa
Zinzino is a global direct sales company specializing in personalized nutrition and scientific skincare. Founded in Scandinavia, Zinzino offers scientifically proven supplements and is publicly traded on Nasdaq First North Premier Growth Market. It also owns several companies, including Zurvita, Xelliss, and HANZZ+HEIDII, and is involved in joint ventures like Cleanthi Alpha-Olenic LTD and BioActive Foods AS.
For more information, visit www.zinzino.com.
Get more information
500+ Largest Direct Sales Companies in 2025 – Top Global List
LifeVantage Expands into Four Asian Markets: Philippines, Taiwan, Hong Kong & Singapore
There are no reviews yet. Be the first one to write one.
